UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's Winrevair to treat a rare lung condition, marking another win...
Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously treated patients...
The CEO of Germany's Merck KGaA said the company's experimental multiple sclerosis drug can be a "blockbuster", an industry term for annual sales that...
Merck & Co said on Tuesday the European Union medicines regulator recommended a marketing authorisation for the company's drug Prevymis to treat a type...
China has granted conditional approval for the import of Merck's COVID-19 treatment Molnupiravir, China's medical products regulator said on Friday.
Molnupiravir, developed by Merck which...
A World Health Organization (WHO) panel on Wednesday backed the use of molnupiravir- Merck & Co's COVID-19 antiviral pill- for high-risk patients.
The expert panel...
UK scientists will begin testing Merck and Ridgeback Biotherapeutics' antiviral pill molnupiravir as a possible treatment for patients hospitalised with COVID-19, amid the worldwide...
A UN-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck's COVID-19 pill molnupiravir for poorer nations,...
Indian drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir, and price it at 35 rupees (Rs70...
A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck, part of Prime Minister Fumio Kishida's plan...
France has cancelled its order for Merck's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the...
The EU's drug watchdog on Friday backed Merck's anti-Covid pill for emergency use ahead of its formal authorisation and started reviewing Pfizer's antiviral treatment...
Indonesia is reviewing a COVID-19 experimental antiviral pill- molnupiravir- produced by Merck for domestic use, its food and drug agency (BPOM) chief said on...
Pfizer and Merck have developed experimental antiviral pills that have shown promising efficacy in trials of adults with COVID-19 who are at high risk...
Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill -molnupiravir- jointly developed by Merck and...
Merck has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) that will allow more companies to manufacture generic versions of...